ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
120.261,34
0,53%
S&P 500
5.487,03
0,25%
US Dollar vs BRL
5,4235
-0,01%
Bitcoin
65.504,93
0,83%
Brent Oil
84,555
-0,17%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Myriad Genetics Inc (MYGN)

  7. Myriad Genetics Inc (MYGN) Notícias

MYGN Myriad Genetics Inc

23,90
-0,13 (-0,54%)
18 Jun 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Myriad Genetics Inc MYGN NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
Upgrade Icon
-0,13 -0,54% 23,90 19:37:36
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
24,06 23,41 24,26 23,90 24,03
mais cotações »

Notícias Recentes

Data Hora Fonte Título
11/06/202409:00GLOBEMyriad Genetics Collaborates with GSK to Improve Access to..
04/06/202410:00GLOBEMyriad Genetics Launches New Universal Plus Panel for..
03/06/202417:05GLOBEGenetics in Medicine Publishes Myriad Genetics..
30/05/202418:55GLOBEQIAGEN and Myriad Genetics develop distributable homologous..
23/05/202419:00GLOBEMyriad Genetics Showcases New Research and Product..
16/05/202417:05GLOBENew Study Published in JCO Precision Oncology Shows Myriad..
08/05/202409:23IHMARKETNEWSReddit Rises 15% After First Quarterly Report, Upstart and..
07/05/202417:05GLOBEMyriad Genetics Reports Strong First Quarter 2024 Financial..
07/05/202410:00GLOBEMyriad Genetics Announces Reorganization of European..
30/04/202417:05GLOBEMyriad Genetics to Release First Quarter 2024 Financial..
17/04/202409:00GLOBENearly Half of Americans Say They’ve Lost Time in Their..
16/04/202410:15GLOBENew Myriad Genetics Study Published in Prenatal Diagnosis..
09/04/202409:00GLOBEMyriad Genetics Research Shows Reduction in Hospitalizations..
21/03/202422:40GLOBEMyriad Genetics Announces Foundational Patent Granted for..
20/03/202417:05GLOBEMyriad Genetics Announces Patent Granted for SneakPeek® Snap..
27/02/202418:05GLOBEMyriad Genetics Reports Strong Fourth Quarter and Full-Year..
27/02/202411:15GLOBEMyriad Genetics and National Cancer Center Hospital East in..
21/02/202418:05GLOBEMyriad Genetics to Release Fourth Quarter and Full Year 2023..
15/02/202418:05GLOBEMyriad Genetics Appoints Dallas Reed, MD, FACOG, FACMG as..
01/02/202411:25GLOBEMyriad Genetics Completes Acquisition of Precise Tumor,..
30/01/202419:00GLOBEMyriad Genetics Names George Daneker Jr., MD, as President..
18/01/202420:10GLOBEMyriad Genetics to Acquire Precise Tumor, Precise Liquid and..
09/01/202418:05GLOBEMyriad Genetics Applauds New Germline Testing Guideline for..
03/01/202418:05GLOBEMyriad Genetics to Present at 42nd Annual J.P. Morgan..
21/12/202310:30GLOBEMyriad Genetics Chief Financial Officer Bryan Riggsbee..
20/12/202310:00GLOBEMyriad Genetics Establishes Comprehensive Pan-Cancer..
20/11/202318:05GLOBEMyriad Genetics Celebrates One Million SneakPeek® Results..
16/11/202318:05GLOBEMyriad Genetics and Personalis Partner to Market..
09/11/202309:00GLOBEMyriad Genetics to Participate in Stephens Annual Investment..
08/11/202323:20GLOBEMyriad Genetics Announces Pricing of Upsized Offering of..
08/11/202318:10GLOBEMyriad Genetics Announces Proposed Offering of $100 Million..
06/11/202318:05GLOBEMyriad Genetics Reports Third Quarter 2023 Financial..
01/11/202310:00GLOBEMyriad Genetics Appoints Sam Raha as Chief Operating Officer
31/10/202317:05GLOBEMyriad Genetics to Release Third Quarter Financial Results..
26/10/202309:00GLOBEQIAGEN and Myriad Genetics partner to advance companion..
28/09/202317:59PRNUSBREAST CANCER AWARENESS MONTH: NEW CANCER RISK SURVEY..
28/09/202308:00GLOBENew Myriad Genetics Survey Shows Breast Cancer Risk Factors..
19/09/202310:00GLOBEMyriad Genetics and Illumina Achieve Milestones in Strategic..
19/09/202308:00GLOBEMyriad Genetics Issues 2022 Environmental, Social and..
18/09/202309:00GLOBEMyriad Genetics and Leading Cancer Center Collaborate to..
06/09/202317:05GLOBEMyriad Genetics Named to 2023 Best Workplaces in Health Care..
06/09/202308:00GLOBENew Myriad Genetics Survey Reveals Widespread Confusion and..
05/09/202309:00GLOBEMyriad Genetics to Participate in Morgan Stanley Global..
22/08/202310:00GLOBEMyriad Genetics and Onsite Women’s Health Partner to Help..
17/08/202317:05GLOBEMyriad Genetics to Host Investor Day on September 19, 2023
15/08/202308:05GLOBEMyriad Genetics Advances Prostate Cancer Care with Addition..
08/08/202317:05GLOBEMyriad Genetics and Intermountain Health Participate in..
07/08/202317:05GLOBEMyriad Genetics Announces Enhancements to the GeneSight®..
03/08/202317:05GLOBEMyriad Genetics Reports Second Quarter 2023 Financial..
27/07/202317:05GLOBEMyriad Genetics to Release Second Quarter Financial Results..

Seu Histórico Recente

NASDAQ
MYGN
Myriad Genetics
BOV
FESA4
FERBASA PN
TSXV
LONE
Lithium One Metals
NASDAQI
SX351010PI
OMX Stockholm Real Estat...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados